Breaking News Instant updates and real-time market news.

2021-12-02 07:20:03 MAIN Main Street $44.09 / -0.37 (-0.83%) 07:20 12/02/21 12/02 07:20 12/02/21 07:20	Main Street announces new portfolio investments Main Street Capital is pleased to announce that it recently completed a new portfolio investment to facilitate the majority recapitalization of Verified Credentials, a consumer reporting agency specializing in pre-employment background checks and ancillary related services. Main Street, along with its co-investor, partnered with Iron Creek Partners, a sector-focused private investor that Main Street has partnered with on multiple prior investments over the last decade, and Verified's existing owner and senior management team to facilitate the transaction and provide growth capital. Main Street and its co-investor also partnered with Iron Creek on two additional investments in the background screening space, Credential Check Corporation and Midwest Backgrounds, with Main Street funding $38.4M in a combination of first lien, senior secured term debt and direct minority equity investments across the companies.

2021-12-02 07:20:03

MAIN

Main Street

$44.09 / -0.37 (-0.83%)

07:20

12/02/21

12/02

07:20

12/02/21

07:20

Main Street announces new portfolio investments

Main Street Capital is pleased to announce that it recently completed a new portfolio investment to facilitate the majority recapitalization of Verified Credentials, a consumer reporting agency specializing in pre-employment background checks and ancillary related services. Main Street, along with its co-investor, partnered with Iron Creek Partners, a sector-focused private investor that Main Street has partnered with on multiple prior investments over the last decade, and Verified's existing owner and senior management team to facilitate the transaction and provide growth capital. Main Street and its co-investor also partnered with Iron Creek on two additional investments in the background screening space, Credential Check Corporation and Midwest Backgrounds, with Main Street funding $38.4M in a combination of first lien, senior secured term debt and direct minority equity investments across the companies.

OTHER BREAKING NEWS FROM THE FLY

Initiation	Krystal Biotech initiated with a Buy at BofA » 06:26 01/18/22 01/18 06:26 01/18/22 06:26 KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) BofA analyst Alec… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 12/06/21 Point72 Asset Management takes 5.4% passive stake in Krystal Biotech 11/29/21 Krystal Biotech says GEM-3 trial met primary endpoint, secondary endpoint 11/19/21 Jeune Aesthetics to present pre-clinical data on KB303 in elastin production 11/08/21 Krystal Biotech announces upcoming milestones KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 06:18 Today BofA Krystal Biotech initiated with a Buy at BofA 11/29/21 H.C. Wainwright Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright 07/20/21 Fly Intel: Top five analyst upgrades 07/20/21 Goldman Sachs Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 11/08/21 Krystal Biotech reports Q3 EPS (70c), consensus (74c) 08/09/21 Krystal Biotech reports Q2 EPS (74c), consensus (76c) 01 Dec 03 Feb KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 11/29/21 Fly Intel: After-Hours Movers 11/29/21 Wall Street in Fives - Must Read Lists for Monday 11/29/21 Wall Street in Fives - Must Read Lists at Midday 11/29/21 Fly Intel: Pre-market Movers
Upgrade	Green Plains upgraded to Outperform from In Line at Evercore ISI » 06:26 01/18/22 01/18 06:26 01/18/22 06:26 GPRE Green Plains $32.38 / -0.48 (-1.46%) Evercore ISI analyst Todd… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events GPRE Green Plains $32.38 / -0.48 (-1.46%) 12/07/21 Green Plains releases inaugural sustainability report 11/12/21 Green Plains director Knudsen sells 64,226 common shares 08/27/21 Green Plains engages Korn Ferry to search for director candidates 08/09/21 Green Plains completes offering of common stock GPRE Green Plains $32.38 / -0.48 (-1.46%) 06:09 Today Evercore ISI Green Plains upgraded to Outperform from In Line at Evercore ISI 12/08/21 Oppenheimer Green Plains initiated with an Outperform at Oppenheimer 11/08/21 Credit Suisse Green Plains price target raised to $49 from $44 at Credit Suisse 11/05/21 BMO Capital Green Plains price target raised to $52 from $43 at BMO Capital GPRE Green Plains $32.38 / -0.48 (-1.46%) 11/04/21 Green Plains reports Q3 EPS ($1.18), consensus (25c) 08/02/21 Green Plains reports Q2 EPS 20c, consensus (23c) 05 Aug 25 Feb GPRE Green Plains $32.38 / -0.48 (-1.46%) 09/22/21 EPA mulling cuts to biofuel blending in win for oil industry, Reuters says GPRE Green Plains $32.38 / -0.48 (-1.46%) 08/05/21 Wall Street in Fives - Must Read Lists for Thursday 08/05/21 Wall Street in Fives - Must Read Lists at Midday 08/02/21 Wall Street in Fives - Must Read Lists for Monday 08/02/21 Wall Street in Fives - Must Read Lists at Midday 02/27/22 27th Annual Energy Summit
Recommendations	Netflix's price increase larger than anticipated, says KeyBanc » 06:25 01/18/22 01/18 06:25 01/18/22 06:25 NFLX Netflix $525.35 / +6.71 (+1.29%) KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $525.35 / +6.71 (+1.29%) 01/14/22 Netflix rallies after announcing plans to raise prices in U.S. 01/14/22 Netflix rallies 2% to $532.02 after Reuters report of U.S. price hike 01/03/22 ViacomCBS shares 'incredibly cheap,' Dan Niles says in blog post 11/26/21 Stay-at-home 'pandemic winners' gain in pre-market amid new COVID variant scare NFLX Netflix $525.35 / +6.71 (+1.29%) 05:09 Today Piper Sandler Piper Sandler remains constructive on Netflix shares into Q4 results 01/14/22 UBS Netflix price target lowered to $690 from $720 at UBS 01/14/22 Wedbush Apple pursuing sports content would be 'right move at right time,' says Wedbush 01/13/22 Credit Suisse Lack of visibility going into Netflix Q4 results, says Credit Suisse NFLX Netflix $525.35 / +6.71 (+1.29%) 10/19/21 Netflix sees Q4 EPS 80c, consensus $1.10 10/19/21 Netflix reports Q3 EPS $3.19, consensus $2.56 10/19/21 Notable companies reporting after market close 07/20/21 Netflix sees Q3 EPS $2.55, consensus $2.17 NFLX Netflix $525.35 / +6.71 (+1.29%) 01/14/22 Netflix increases monthly subscription prices in U.S., Canada, Reuters says 01/06/22 Netflix film 'Don't Look Up' breaks platform weekly streaming record, WSJ says 12/29/21 U.S. media groups to spend over $100B on new content in 2022, FT reports 12/23/21 Research shows TikTok was the most visited internet site in 2021, WSJ reports NFLX Netflix $525.35 / +6.71 (+1.29%) 01/14/22 Wall Street in Fives - Must Read Lists for Friday 12/29/21 Wall Street in Fives - Must Read Lists for Wednesday 12/29/21 #SocialStocks: TikTok declared most visited site in 2021 12/29/21 Wall Street in Fives - Must Read Lists at Midday NFLX Netflix $525.35 / +6.71 (+1.29%) 10/20/21 Notable open interest changes for October 20th 10/19/21 Netflix options imply 8.6% move in share price post-earnings 10/15/21 Notable earnings next week include Netflix, Tesla, Intel and airlines UAL, 10/01/21 Unusual call flow in option market yesterday
Initiation	Westlake Chemical resumed with a Buy at Deutsche Bank » 06:24 01/18/22 01/18 06:24 01/18/22 06:24 WLK Westlake Chemical $107.22 / +2.245 (+2.14%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WLK Westlake Chemical $107.22 / +2.245 (+2.14%) 11/24/21 Westlake Chemical to acquire Hexion's global epoxy business for $1.2B 11/08/21 Westlake Chemical CFO Bender sells 6,356 common shares 10/07/21 Westlake Chemical and Nexii partner for sustainable building 08/31/21 Westlake Chemical says likely incurred limited physical damage from Ida WLK Westlake Chemical $107.22 / +2.245 (+2.14%) 11/29/21 Piper Sandler Westlake Chemical price target raised to $125 from $109 at Piper Sandler 11/22/21 KeyBanc KeyBanc downgrades Celanese, Olin, Westlake Chemical to Sector Weight 11/22/21 KeyBanc Westlake Chemical downgraded to Sector Weight from Overweight at KeyBanc 11/03/21 Wells Fargo Westlake Chemical price target raised to $130 from $125 at Wells Fargo WLK Westlake Chemical $107.22 / +2.245 (+2.14%) 11/02/21 Westlake Chemical reports Q3 EPS $4.69, consensus $3.96 08/03/21 Westlake Chemical reports Q2 EPS $4.04 ex-items, consensus $3.34
Upgrade	First Republic upgraded to Outperform at Evercore ISI following pullback » 06:22 01/18/22 01/18 06:22 01/18/22 06:22 FRC First Republic $192.15 / -8.39 (-4.18%) Evercore ISI analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events FRC First Republic $192.15 / -8.39 (-4.18%) 01/03/22 First Republic reports preliminary Q4 net charge-offs $100,000 01/03/22 First Republic co-CEO Hafize Gaye Erkan resigns, Mike Roffler named co-CEO 12/13/21 First Republic chairman, co-CEO Jim Herbert to take medical leave of absence FRC First Republic $192.15 / -8.39 (-4.18%) 06:11 Today Evercore ISI First Republic upgraded to Outperform from In Line at Evercore ISI 01/12/22 UBS First Republic initiated with a Neutral at UBS 01/10/22 Morgan Stanley First Republic assumed with an Equal Weight at Morgan Stanley 01/03/22 Barclays First Republic price target raised to $223 from $215 at Barclays FRC First Republic $192.15 / -8.39 (-4.18%) 01/14/22 First Republic reports Q4 EPS $2.02, consensus $1.93 10/13/21 First Republic reports Q3 EPS $1.91, consensus $1.84 10 Aug 02 Mar 02/16/22 23rd Annual Financial Services Forum

Recommendations	Lam Research price target raised to $840 from $790 at Berenberg » 06:22 01/18/22 01/18 06:22 01/18/22 06:22 LRCX Lam Research $729.90 / +43.97 (+6.41%) Berenberg analyst Tammy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LRCX Lam Research $729.90 / +43.97 (+6.41%) 09/09/21 Lam Research to open semiconductor equipment manufacturing facility in Oregon 08/31/21 Semi equipment names slip as TSMC looks to lower costs 08/26/21 Lam Research hikes dividend 15% to $1.50 per share 08/13/21 Soros Capital buys Amazon, exits Netflix in Q2 LRCX Lam Research $729.90 / +43.97 (+6.41%) 01/13/22 Mizuho Lam Research price target raised to $770 from $700 at Mizuho 01/12/22 Barclays Lam Research price target raised to $750 from $625 at Barclays 01/05/22 Jefferies Lam Research initiated with a Buy at Jefferies 12/21/21 Wells Fargo Lam Research price target raised to $660 from $575 at Wells Fargo LRCX Lam Research $729.90 / +43.97 (+6.41%) 10/20/21 Lam Research sees Q2 EPS $8.45 +/- 50c, consensus $8.47 10/20/21 Lam Research reports Q1 EPS $8.36, consensus $8.21 10/20/21 Notable companies reporting after market close 07/28/21 Lam Research sees Q1 EPS $8.02, +/- 50c, consensus $7.77 LRCX Lam Research $729.90 / +43.97 (+6.41%) 12/15/21 Biden administration considering tougher sanctions on SMIC, Bloomberg reports LRCX Lam Research $729.90 / +43.97 (+6.41%) 10/21/21 Zoom Video, Twilio initiations among today's top calls on Wall Street 10/20/21 Fly Intel: After-Hours Movers 07/28/21 Fly Intel: After-Hours Movers LRCX Lam Research $729.90 / +43.97 (+6.41%) 01/13/22 Early notable gainers among liquid option names on January 13th 01/13/22 Unusually active option classes on open January 13th 12/13/21 Lam Research call volume above normal and directionally bullish 11/04/21 Lam Research call volume above normal and directionally bullish
Recommendations	Tesla price target raised to $1,025 from $830 at Credit Suisse » 06:22 01/18/22 01/18 06:22 01/18/22 06:22 TSLA Tesla $1,049.72 / +18.72 (+1.82%) Credit Suisse analyst Dan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TSLA Tesla $1,049.72 / +18.72 (+1.82%) 01/14/22 'Tesla merch buyable with Dogecoin,' Elon Musk says via Twitter 01/10/22 Talon Metals announces nickel supply agreement with Tesla 01/07/22 Tesla CEO says FSD price rising to $12,000 on January 17 01/07/22 Tesla CEO says FSD Beta 10.9 ready 'in about a week' TSLA Tesla $1,049.72 / +18.72 (+1.82%) 01/12/22 New Street New Street sees 50% upside in Tesla this year amid 'perfect storm' 01/11/22 Redburn Redburn starts Lucid Group at Neutral on risks of competing against Tesla 01/10/22 Morgan Stanley Tesla price target raised to $1,300 from $1,200 at Morgan Stanley 01/10/22 Goldman Sachs Goldman ups Tesla price target, says best positioned in EVs TSLA Tesla $1,049.72 / +18.72 (+1.82%) 10/20/21 Tesla reports Q3 non-GAAP EPS $1.86, consensus $1.58 10/20/21 Notable companies reporting after market close 07/30/21 Musk sides with Epic, says Apple fees 'de facto global tax' on internet 07/26/21 Tesla reports Q2 non-GAAP EPS $1.45, consensus 96c TSLA Tesla $1,049.72 / +18.72 (+1.82%) 01/13/22 Tesla pushes Cybertruck production start to early 2023, Reuters reports 01/13/22 Tesla scrubs 2022 production date from Cybertruck website, The Verge reports 01/13/22 19-year-old allegedly hacked into over 25 Teslas in 13 countries, NYP reports 01/12/22 California's DMV 'revisiting' Tesla's self-driving beta, LA Times reports TSLA Tesla $1,049.72 / +18.72 (+1.82%) 01/14/22 Wall Street in Fives - Must Read Lists for Friday 01/14/22 Wall Street in Fives - Must Read Lists at Midday 01/14/22 Crypto Currents: Coinbase acquires derivatives exchange FairX 01/13/22 Wall Street in Fives - Must Read Lists for Thursday TSLA Tesla $1,049.72 / +18.72 (+1.82%) 01/13/22 Notable open interest changes for January 13th 01/12/22 Notable open interest changes for January 12th 01/11/22 Notable open interest changes for January 11th 01/10/22 Notable open interest changes for January 10th
Recommendations	KLA Corp. price target raised to $545 from $470 at Berenberg » 06:22 01/18/22 01/18 06:22 01/18/22 06:22 KLAC KLA Corp. $445.18 / +23.55 (+5.59%) Berenberg analyst Tammy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options KLAC KLA Corp. $445.18 / +23.55 (+5.59%) 12/16/21 KLA Corp. targets 100% renewable electricity across global operations by 2030 11/05/21 KLA Corp. officially opens $200M second headquarters in Ann Arbor, Michigan 08/31/21 Semi equipment names slip as TSMC looks to lower costs 07/29/21 KLA Corp. raises dividend 17% to $1.05 per share, announces $2B share buyback KLAC KLA Corp. $445.18 / +23.55 (+5.59%) 01/12/22 Barclays KLA Corp. price target raised to $425 from $350 at Barclays 01/05/22 Jefferies KLA Corp. initiated with a Buy at Jefferies 12/21/21 Fly Intel: Top five analyst upgrades 12/21/21 Wells Fargo KLA Corp. upgraded to Overweight from Equal Weight at Wells Fargo KLAC KLA Corp. $445.18 / +23.55 (+5.59%) 10/27/21 KLA Corp. sees Q2 non-GAAP EPS $4.95-$5.85, consensus $5.14 10/27/21 KLA Corp. reports Q1 non-GAAP EPS $4.64, consensus $4.52 07/29/21 KLA Corp. sees Q1 adjusted EPS $4.01-$4.89, consensus $4.13 07/29/21 KLA Corp. reports Q4 adjusted EPS $4.43, consensus $3.99 KLAC KLA Corp. $445.18 / +23.55 (+5.59%) 12/15/21 Biden administration considering tougher sanctions on SMIC, Bloomberg reports KLAC KLA Corp. $445.18 / +23.55 (+5.59%) 12/21/21 Wall Street in Fives - Must Read Lists for Tuesday 12/21/21 Wall Street in Fives - Must Read Lists at Midday 10/27/21 Fly Intel: After-Hours Movers 09/14/21 Wall Street in Fives - Must Read Lists at Midday KLAC KLA Corp. $445.18 / +23.55 (+5.59%) 01/13/22 Early notable gainers among liquid option names on January 13th 10/28/21 Early notable gainers among liquid option names on October 28th 10/22/21 Early notable gainers among liquid option names on October 22nd 09/10/21 Early notable gainers among liquid option names on September 10th
Recommendations	Applied Materials price target raised to $205 from $160 at Berenberg » 06:22 01/18/22 01/18 06:22 01/18/22 06:22 AMAT Applied Materials $167.01 / +9.855 (+6.27%) Berenberg analyst Tammy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AMAT Applied Materials $167.01 / +9.855 (+6.27%) 12/23/21 Applied Materials, Institute of Microelectronics expand research pact 10/18/21 Applied Materials unveils eBeam metrology system 10/01/21 Adobe appoints Dan Durn as executive vice president, CFO 10/01/21 Applied Materials appoints Bob Halliday as interim CFO AMAT Applied Materials $167.01 / +9.855 (+6.27%) 01/13/22 Mizuho Applied Materials price target raised to $178 from $161 at Mizuho 01/12/22 Barclays Applied Materials price target raised to $165 from $150 at Barclays 01/05/22 Jefferies Applied Materials initiated with a Buy at Jefferies 12/15/21 Deutsche Bank Applied Materials price target raised to $180 from $170 at Deutsche Bank AMAT Applied Materials $167.01 / +9.855 (+6.27%) 11/18/21 Applied Materials sees Q1 EPS $1.78-$1.92, consensus $2.01 11/18/21 Applied Materials reports Q4 EPS $1.94, consensus $1.95 11/18/21 Notable companies reporting after market close 08/19/21 Applied Materials sees Q4 adjusted EPS $1.87-$2.01, consensus $1.81 AMAT Applied Materials $167.01 / +9.855 (+6.27%) 12/15/21 Biden administration considering tougher sanctions on SMIC, Bloomberg reports AMAT Applied Materials $167.01 / +9.855 (+6.27%) 11/19/21 Wall Street in Fives - Must Read Lists for Friday 11/19/21 Wall Street in Fives - Must Read Lists at Midday 11/19/21 Fly Intel: Pre-market Movers 11/18/21 Fly Intel: After-Hours Movers AMAT Applied Materials $167.01 / +9.855 (+6.27%) 01/13/22 Applied Materials call volume above normal and directionally bullish 11/18/21 Applied Materials options imply 3.4% move in share price post-earnings 10/22/21 Early notable gainers among liquid option names on October 22nd 09/13/21 Applied Materials call volume above normal and directionally bullish
Downgrade	Brandywine Realty downgraded to Hold from Buy at Truist » 06:21 01/18/22 01/18 06:21 01/18/22 06:21 BDN Brandywine Realty $14.31 / -0.04 (-0.28%) Truist analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events BDN Brandywine Realty $14.31 / -0.04 (-0.28%) 04/14/21 Mizuho Brandywine Realty price target raised to $13 from $12 at Mizuho 03/22/21 Evercore ISI Evercore downgrades Brandywine Realty to In Line following outperformance 03/22/21 Evercore ISI Brandywine Realty downgraded to In Line from Outperform at Evercore ISI BDN Brandywine Realty $14.31 / -0.04 (-0.28%) 10/25/21 Brandywine Realty tightens FY21 FFO view to $1.35-$1.39 from $1.34-$1.40 10/25/21 Brandywine Realty reports Q3 FFO 35c, consensus 34c 07/26/21 Brandywine Realty narrows FY21 FFO view to $1.34-$1.40 from $1.33-$1.41 07/26/21 Brandywine Realty reports Q2 FFO 32c, two estimates 32c 02/23/22 25th Annual Wells Fargo Real Estate Securities Conference 02/03/22 Brandywine Realty - BDN

Recommendations	Citi price target lowered to $85 from $88 at Piper Sandler » 06:19 01/18/22 01/18 06:19 01/18/22 06:19 C Citi $66.93 / -0.89 (-1.31%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options C Citi $66.93 / -0.89 (-1.31%) 01/14/22 Citi pursuing multiple divestiture paths for Mexico consumer unit 01/14/22 Citi is largest custodian for BlackRock's iShares ETF, says CEO Fraser 01/14/22 Citi to resume share buybacks this quarter, says CEO Fraser 01/14/22 Citi sees starting sales process of Mexico unit in the spring, says CEO Fraser C Citi $66.93 / -0.89 (-1.31%) 01/12/22 JPMorgan Citi 'continues to dismantle itself,' says JPMorgan 01/06/22 JPMorgan Citi price target lowered to $76 from $80.50 at JPMorgan 01/03/22 Barclays Citi price target lowered to $73 from $86 at Barclays 12/15/21 Odeon Capital Citi upgraded to Buy from Hold at Odeon Capital C Citi $66.93 / -0.89 (-1.31%) 01/14/22 Citi reports Q4 EPS $1.46, consensus $1.37 01/13/22 Notable companies reporting before tomorrow's open 01/13/22 Notable companies reporting before tomorrow's open 10/14/21 Citi reports Q3 EPS $2.15, consensus $1.65 C Citi $66.93 / -0.89 (-1.31%) 01/12/22 Santander exploring bid for Citi operations in Mexico, Blomberg reports 01/09/22 Citigroup to fire unvaccinated staff this month, Reuters reports 01/07/22 Citi to fire Covid vaccine holdouts at end of month, Bloomberg reports 01/05/22 SEC Texas office investigates banks over gun, fossil fuel policies, Reuters says C Citi $66.93 / -0.89 (-1.31%) 01/14/22 Wall Street in Fives - Must Read Lists for Friday 01/14/22 Wall Street in Fives - Must Read Lists at Midday 01/14/22 Fly Intel: Pre-market Movers 01/13/22 Fly Intel: What to watch in first round of big bank earnings reports 02/07/22 SIFMA's Anti-Money Laundering & Financial Crimes Conference C Citi $66.93 / -0.89 (-1.31%) 01/07/22 Unusually active option classes on open January 7th 01/06/22 Citi put buyer realizes 42% same-day gains 11/19/21 Heavy early trading in Citibank options as shares dip 11/11/21 Notable open interest changes for November 11th
Periodicals	Horta-Osorio lost Credit Suisse board support over Covid rules breach, WSJ says » 06:19 01/18/22 01/18 06:19 01/18/22 06:19 CS Credit Suisse $10.55 / +0.04 (+0.38%) Antonio Horta-Osorio, who… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CS Credit Suisse $10.55 / +0.04 (+0.38%) 01/17/22 Credit Suisse Chairman Horta-Osorio resigns after board investigation 12/13/21 Credit Suisse appoints Francesco De Ferrari as CEO of wealth management 12/02/21 EU fines UBS, Barclays, RBS, HSBC, Credit Suisse EUR344M over forex probe 11/15/21 Cooperman's Omega Advisors buys Las Vegas Sands, exits Ferro in Q3 CS Credit Suisse $10.55 / +0.04 (+0.38%) 01/07/22 Exane BNP Paribas Credit Suisse downgraded to Neutral from Outperform at Exane BNP Paribas 01/06/22 JPMorgan Credit Suisse price target raised to CHF 10.60 from CHF 10.40 at JPMorgan 01/06/22 Keefe Bruyette Credit Suisse downgraded to Underperform from Market Perform at Keefe Bruyette 12/06/21 UBS Credit Suisse downgraded to Neutral from Buy at UBS CS Credit Suisse $10.55 / +0.04 (+0.38%) 11/04/21 Credit Suisse reports Q3 net revenue CHF 5.44B vs. CHF 5.2B last year 07/29/21 Credit Suisse reports Q2 net revenue CHF 5.1B vs. CHF 6.19B last year CS Credit Suisse $10.55 / +0.04 (+0.38%) 01/11/22 Credit Suisse poised to name Wah, Welter as co-heads of banking, Bloomberg says 12/30/21 Credit Suisse chairman breaks COVID-19 rules for second time, Reuters says 12/26/21 Credit Suisse seeking SoftBank subpoena, readies U.K. suit, Bloomberg reports 12/22/21 Credit Suisse managers responsible for Greensill funds fired, FT reports CS Credit Suisse $10.55 / +0.04 (+0.38%) 12/30/21 Wall Street in Fives - Must Read Lists at Midday 12/22/21 Wall Street in Fives - Must Read Lists at Midday 12/17/21 Wall Street in Fives - Must Read Lists for Friday 12/17/21 Wall Street in Fives - Must Read Lists at Midday CS Credit Suisse $10.55 / +0.04 (+0.38%) 09/20/21 Unusually active option classes on open September 20th
Downgrade	Duke Realty downgraded to Hold from Buy at Truist » 06:18 01/18/22 01/18 06:18 01/18/22 06:18 DRE Duke Realty / + Truist analyst Ki Bin Kim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Periodicals Events DRE Duke Realty / + 01/13/22 Mizuho Duke Realty price target raised to $65 from $50 at Mizuho 01/07/22 BMO Capital Duke Realty downgraded to Market Perform from Outperform at BMO Capital 12/09/21 BofA Rexford Industrial added to US 1 List; Duke Realty & Disney removed at BofA 11/19/21 RBC Capital Duke Realty upgraded to Outperform from Sector Perform at RBC Capital DRE Duke Realty / + 10/27/21 Duke Realty raises FY21 core FFO view to $1.71-$1.75 from $1.69-$1.73 10/27/21 Duke Realty reports Q3 core FFO EPS 46c, consensus 44c 07/28/21 Duke Realty raises FY21 FFO view to $1.69-$1.73 from $1.65-$1.71 07/28/21 Duke Realty reports Q2 core FFO EPS 44c, consensus 43c DRE Duke Realty / + 11/22/21 'Amazon-linked' industrial developer 'eyes' Oakland project, Mercury News says 02/23/22 25th Annual Wells Fargo Real Estate Securities Conference
Initiation	Krystal Biotech initiated with a Buy at BofA » 06:18 01/18/22 01/18 06:18 01/18/22 06:18 KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) BofA analyst Alec… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 12/06/21 Point72 Asset Management takes 5.4% passive stake in Krystal Biotech 11/29/21 Krystal Biotech says GEM-3 trial met primary endpoint, secondary endpoint 11/19/21 Jeune Aesthetics to present pre-clinical data on KB303 in elastin production 11/08/21 Krystal Biotech announces upcoming milestones KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 11/29/21 H.C. Wainwright Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright 07/20/21 Fly Intel: Top five analyst upgrades 07/20/21 Goldman Sachs Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs 07/09/21 Chardan Krystal Biotech coverage transferred at Chardan KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 11/08/21 Krystal Biotech reports Q3 EPS (70c), consensus (74c) 08/09/21 Krystal Biotech reports Q2 EPS (74c), consensus (76c) 01 Dec 03 Feb KRYS Krystal Biotech $62.18 / +1.195 (+1.96%) 11/29/21 Fly Intel: After-Hours Movers 11/29/21 Wall Street in Fives - Must Read Lists for Monday 11/29/21 Wall Street in Fives - Must Read Lists at Midday 11/29/21 Fly Intel: Pre-market Movers
Initiation	Vtex initiated with an Overweight at Piper Sandler » 06:18 01/18/22 01/18 06:18 01/18/22 06:18 VTEX Vtex $7.55 / -0.175 (-2.27%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options VTEX Vtex $7.55 / -0.175 (-2.27%) 11/17/21 Vtex falls -6.0% 11/15/21 Lone Pine boosts Twitter stake, reduces Meta Platforms stake 11/15/21 Tiger Global boosts stake in Snowflake, exits TAL Education Group 09/30/21 Vtex launches new global integration with Facebook VTEX Vtex $7.55 / -0.175 (-2.27%) 04:52 Today Goldman Sachs Vtex upgraded to Buy from Neutral at Goldman Sachs 09/24/21 Morgan Stanley Vtex upgraded to Overweight from Equal Weight at Morgan Stanley 08/16/21 JPMorgan Vtex initiated with a Neutral at JPMorgan 08/16/21 Morgan Stanley Vtex initiated with an Equal Weight at Morgan Stanley VTEX Vtex $7.55 / -0.175 (-2.27%) 11/17/21 Vtex backs FY21 revenue view $124M-$126M, consensus $124.59M 11/17/21 Vtex sees Q4 revenue $35.3M-$37.3M, consensus $36.93M 11/17/21 Vtex reports Q3 EPS (12c), consensus (10c) 21 Jul VTEX Vtex $7.55 / -0.175 (-2.27%) 12/03/21 The Five Stocks Billionaire Paul Singer Is Betting Big On 08/07/21 Opening Day: European Wax Center jumps in first trading day 07/24/21 Opening Day: Zoom Video rival Kaltura rises in market debut VTEX Vtex $7.55 / -0.175 (-2.27%) 11/24/21 Nine new option listings on November 24th

Recommendations	JPMorgan price target lowered to $187 from $192 at Piper Sandler » 06:18 01/18/22 01/18 06:18 01/18/22 06:18 JPM JPMorgan $157.90 / -10.415 (-6.19%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JPM JPMorgan $157.90 / -10.415 (-6.19%) 01/14/22 JPMorgan CFO says buybacks at 'bottom of list' for 2022 01/14/22 JPMorgan CFO: We are in for a couple of years of sub-target returns 01/14/22 JPMorgan CEO Dimon says costs will likely rise in 2023 01/14/22 JPMorgan sees 2022 net interest income of $50B ex-CIB Markets JPM JPMorgan $157.90 / -10.415 (-6.19%) 01/17/22 Keefe Bruyette JPMorgan price target lowered to $157 from $166 at Keefe Bruyette 01/17/22 Credit Suisse Credit Suisse keeps $184 target on JPMorgan, says playing the long game 01/14/22 Wells Fargo Wells Fargo downgrades 'expensive' JPMorgan to Equal Weight on high expenses 01/14/22 Wells Fargo JPMorgan downgraded to Equal Weight from Overweight at Wells Fargo JPM JPMorgan $157.90 / -10.415 (-6.19%) 01/14/22 JPMorgan reports Q4 EPS $3.33, consensus $3.01 01/13/22 Notable companies reporting before tomorrow's open 01/13/22 Notable companies reporting before tomorrow's open 10/13/21 JPMorgan reports Q3 adjusted EPS $3.03, consensus $3.00 JPM JPMorgan $157.90 / -10.415 (-6.19%) 01/12/22 Workers at Google, BlackRock getting Covid home tests for free, NY Times reports 01/05/22 SEC Texas office investigates banks over gun, fossil fuel policies, Reuters says 01/03/22 Goldman asks U.S. employees to work from home for next few weeks, NYT says 12/31/21 JPMorgan, Citi encourage workers working remotely in January, Bloomberg reports JPM JPMorgan $157.90 / -10.415 (-6.19%) 01/14/22 Wall Street in Fives - Must Read Lists for Friday 01/14/22 Wall Street in Fives - Must Read Lists at Midday 01/14/22 Fly Intel: Pre-market Movers 01/13/22 Fly Intel: What to watch in first round of big bank earnings reports 02/07/22 SIFMA's Anti-Money Laundering & Financial Crimes Conference JPM JPMorgan $157.90 / -10.415 (-6.19%) 01/14/22 Unusually active option classes on open January 14th 01/04/22 Unusually active option classes on open January 4th 11/24/21 Unusually active option classes on open November 24th 08/26/21 JPMorgan call volume above normal and directionally bullish
Upgrade	Oppenheimer upgrades Six Flags to Outperform with $54 price target » 06:17 01/18/22 01/18 06:17 01/18/22 06:17 SIX Six Flags $40.65 / -0.87 (-2.10%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SIX Six Flags $40.65 / -0.87 (-2.10%) 11/15/21 Six Flags CEO Michael Spanos steps down, Selim Bassoul succeeds 10/27/21 Six Flags falls -8.4% 10/06/21 Six Flags partners with Clear Secure for proof of vaccination at Magic Mountain 09/07/21 Volta partners with Six Flags for electric vehicle charging SIX Six Flags $40.65 / -0.87 (-2.10%) 05:39 Today Oppenheimer Six Flags upgraded to Outperform from Perform at Oppenheimer 12/17/21 Credit Suisse Six Flags upgraded to Outperform from Neutral at Credit Suisse 12/14/21 Goldman Sachs Six Flags upgraded to Buy at Goldman after leisure group correction 12/14/21 Goldman Sachs Six Flags upgraded to Buy from Neutral at Goldman Sachs SIX Six Flags $40.65 / -0.87 (-2.10%) 10/27/21 Six Flags reports Q3 EPS $1.80, consensus $1.55 10/26/21 Notable companies reporting before tomorrow's open 10/26/21 Notable companies reporting before tomorrow's open 07/28/21 Six Flags reports Q2 EPS 81c, consensus (7c) SIX Six Flags $40.65 / -0.87 (-2.10%) 07/19/21 Chemical incident occurs at Six Flags waterpark in Texas, CBS News reports SIX Six Flags $40.65 / -0.87 (-2.10%) 12/17/21 Wall Street in Fives - Must Read Lists for Friday 12/17/21 Wall Street in Fives - Must Read Lists at Midday 12/17/21 Six Flags upgrade, Starbucks downgrade among today's top calls on Wall Street 12/14/21 Fly Intel: After-Hours Movers
Recommendations	Washington Federal price target raised to $37 from $34 at Piper Sandler » 06:16 01/18/22 01/18 06:16 01/18/22 06:16 WAFD Washington Federal $37.49 / +0.72 (+1.96%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options WAFD Washington Federal $37.49 / +0.72 (+1.96%) 12/20/21 Washington Federal announces termination of AML/BSA consent order 09/30/21 Washington Federal agrees to $2.5M civil penalty with OCC WAFD Washington Federal $37.49 / +0.72 (+1.96%) 10/18/21 DA Davidson Washington Federal price target raised to $39 from $34 at DA Davidson WAFD Washington Federal $37.49 / +0.72 (+1.96%) 01/13/22 Washington Federal reports Q1 EPS 71c, two estimates 69c 10/14/21 Washington Federal reports Q4 EPS 72c, consensus 63c WAFD Washington Federal $37.49 / +0.72 (+1.96%) 10/14/21 Fly Intel: After-Hours Movers 01/25/22 Washington Federal, Inc. WAFD Washington Federal $37.49 / +0.72 (+1.96%) 01/13/22 Washington Federal options imply 3.0% move in share price post-earnings 10/14/21 Washington Federal options imply 3.1% move in share price post-earnings
Hot Stocks	Ford signs five-year payments deal with Stripe » 06:15 01/18/22 01/18 06:15 01/18/22 06:15 F Ford $25.19 / +0.18 (+0.72%) Ford Motor Company and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options F Ford $25.19 / +0.18 (+0.72%) 01/14/22 Ford reports China Q4 sales up 11.9% quarter-over-quarter to over 167,000 units 01/05/22 Ford reports Q4 U.S. sales up 26.8% from Q3 to 508,451 vehicles 01/05/22 Ford reports December U.S. sales down 17.1% to 173,740 vehicles 01/04/22 Intel subsidiary Mobileye announces new strategic collaborations F Ford $25.19 / +0.18 (+0.72%) 01/14/22 RBC Capital Ford downgraded to Sector Perform at RBC Capital on reduced near-term upside 01/14/22 RBC Capital Ford downgraded to Sector Perform from Outperform at RBC Capital 01/13/22 Deutsche Bank Deutsche Bank sees 2022 guidance misses from these auto companies 01/13/22 Deutsche Bank Ford price target raised to $24 from $18 at Deutsche Bank F Ford $25.19 / +0.18 (+0.72%) 10/27/21 Ford raises FY21 adjusted EBIT view to $10.5B-$11.5B from $9B-$10B 10/27/21 Ford reports Q3 adjusted EPS 51c, consensus 27c 10/27/21 Notable companies reporting after market close 07/28/21 Ford reports Q2 EPS 13c, consensus (10c) F Ford $25.19 / +0.18 (+0.72%) 12/20/21 Ford's Mustang Mach-E becomes part of NYC's yellow taxi fleet, Verge says 12/15/21 Google, Ford, Uber delay office return due to omicron variant, WSJ reports 12/10/21 Ford delays output start of Explorer, Aviator EVs, Automotive News says 12/10/21 GM to start Silverado EV production in early 2023, Automotive News reports F Ford $25.19 / +0.18 (+0.72%) 01/15/22 Opening Day: TPG raises $1B in first big IPO of 2022 01/14/22 Wall Street in Fives - Must Read Lists for Friday 01/14/22 Wall Street in Fives - Must Read Lists at Midday 01/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations F Ford $25.19 / +0.18 (+0.72%) 01/14/22 Notable open interest changes for January 14th 01/13/22 Notable open interest changes for January 13th 01/10/22 Notable open interest changes for January 10th 01/07/22 Notable open interest changes for January 7th
Upgrade	Brixmor upgraded to Buy from Hold at Truist » 06:15 01/18/22 01/18 06:15 01/18/22 06:15 BRX Brixmor $26.51 / -0.27 (-1.01%) Truist analyst Ki Bin Kim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings BRX Brixmor $26.51 / -0.27 (-1.01%) 01/10/22 Jefferies Brixmor upgraded to Buy from Hold at Jefferies 12/01/21 Truist Brixmor price target raised to $26 from $23 at Truist 12/01/21 BMO Capital Brixmor upgraded to Market Perform from Underperform at BMO Capital 11/19/21 Compass Point Brixmor upgraded to Buy from Neutral at Compass Point BRX Brixmor $26.51 / -0.27 (-1.01%) 11/01/21 Brixmor narrows FY21 NAREIT FFO view to $1.72-$1.75 from $1.70-$1.76 11/01/21 Brixmor reports Q3 NAREIT FFO 39c, consensus 34c 08/02/21 Brixmor raises FY21 FFO view to $1.70-$1.76 from $1.60-$1.70, consensus $1.69 08/02/21 Brixmor reports Q2 FFO 46c, consensus 42c

Recommendations	UroGen Pharma price target lowered to $34 from $50 at H.C. Wainwright » 06:15 01/18/22 01/18 06:15 01/18/22 06:15 URGN UroGen Pharma $8.49 / +0.15 (+1.80%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings URGN UroGen Pharma $8.49 / +0.15 (+1.80%) 12/21/21 UroGen Pharma announces first patient dosed in UGN-102 study 11/10/21 UroGen Pharma unveils Phase 3 development plan for UGN-102 08/02/21 Allogene Therapeutics appoints Barrett, Sato to board of directors 07/28/21 UroGen Pharma announces license, supply agreement with Neopharm URGN UroGen Pharma $8.49 / +0.15 (+1.80%) 04/27/21 H.C. Wainwright UroGen Pharma price target lowered to $50 from $57 at H.C. Wainwright URGN UroGen Pharma $8.49 / +0.15 (+1.80%) 11/15/21 UroGen Pharma reports Q3 EPS ($1.35), consensus ($1.29) 08/04/21 UroGen Pharma reports Q2 EPS ($1.17), consensus ($1.27)
Upgrade	Limelight Networks upgraded to Buy from Hold at Truist » 06:14 01/18/22 01/18 06:14 01/18/22 06:14 LLNW Limelight Networks $3.49 / +0.025 (+0.72%) Truist analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options LLNW Limelight Networks $3.49 / +0.025 (+0.72%) 07/28/21 Limelight Networks to acquire Layer0 LLNW Limelight Networks $3.49 / +0.025 (+0.72%) 12/20/21 Raymond James Limelight Networks upgraded to Strong Buy from Market Perform at Raymond James 10/15/21 Craig-Hallum Limelight Networks upgraded to Buy from Hold at Craig-Hallum 10/15/21 Craig-Hallum Limelight Networks upgraded to Buy from Hold at Craig-Hallum 08/09/21 Raymond James Limelight Networks reinstated with a Market Perform at Raymond James LLNW Limelight Networks $3.49 / +0.025 (+0.72%) 11/04/21 Limelight Networks lowers FY21 non-GAAP EPS view to (17c)-(12c) from (15c)-(5c) 11/04/21 Limelight Networks reports Q3 non-GAAP EPS (1c), consensus (1c) 07/29/21 Limelight Networks reports Q2 non-GAAP EPS (6c), consensus (3c) LLNW Limelight Networks $3.49 / +0.025 (+0.72%) 07/29/21 Fly Intel: After-Hours Movers LLNW Limelight Networks $3.49 / +0.025 (+0.72%) 11/04/21 Limelight Networks options imply 13.6% move in share price post-earnings
Recommendations	Rockwell Medical price target lowered to $3 from $5 at H.C. Wainwright » 06:13 01/18/22 01/18 06:13 01/18/22 06:13 RMTI Rockwell Medical / + H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research RMTI Rockwell Medical / + 01/13/22 Rockwell Medical announces regulatory approval of Triferic AVNU in South Korea 12/14/21 Rockwell receives feedback from FDA on IND application for Phase 2 trial of FPC 11/16/21 Rockwell Medical publishes data on Ferric Pyrophosphate Citrate with UFH 11/11/21 Rockwell Medical submits IND with FDA for proposed clinical trial of FPC RMTI Rockwell Medical / + 02/08/21 H.C. Wainwright Rockwell Medical price target lowered to $5.50 from $9 at H.C. Wainwright
Hot Stocks	Rayonier Advanced Materials investing in second generation bioethanol plant » 06:13 01/18/22 01/18 06:13 01/18/22 06:13 RYAM Rayonier Advanced Materials $6.61 / -0.015 (-0.23%) Rayonier Advanced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RYAM Rayonier Advanced Materials $6.61 / -0.015 (-0.23%) 01/13/22 Rayonier Advanced Materials facility granted ISCC Plus certification 12/06/21 Rayonier Advanced Materials: Vito Consiglio to succeed Paul Boynton as CEO 10/04/21 Rayonier Advanced Materials increases price for cellulose specialties products 09/10/21 Rayonier Advanced Materials rises 8.1% RYAM Rayonier Advanced Materials $6.61 / -0.015 (-0.23%) 12/15/21 BofA Rayonier Advanced Materials downgraded to Underperform from Buy at BofA 08/05/21 RBC Capital Rayonier Advanced Materials upgraded to Outperform at RBC 08/05/21 RBC Capital Rayonier Advanced Materials upgraded to Outperform from Sector Perform at RBC Capital 05/05/21 RBC Capital Rayonier Advanced Materials cut to Sector Perform from Outperform at RBC Capital RYAM Rayonier Advanced Materials $6.61 / -0.015 (-0.23%) 11/02/21 Rayonier Advanced Materials reports Q3 adjusted EPS (21c), consensus 2c 08/03/21 Rayonier Advanced Materials reports Q2 EPS $1.89, consensus 74c
Recommendations	Taro Pharmaceutical price target lowered to $75 from $82 at H.C. Wainwright » 06:13 01/18/22 01/18 06:13 01/18/22 06:13 TARO Taro Pharmaceutical $48.58 / -0.825 (-1.67%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TARO Taro Pharmaceutical $48.58 / -0.825 (-1.67%) 12/01/21 Taro Pharmaceutical appoints William Coote CFO 10/01/21 Three generic drug makers to pay $447.2M to settle price-fixing claims, DOJ says TARO Taro Pharmaceutical $48.58 / -0.825 (-1.67%) 07/28/21 H.C. Wainwright Taro Pharmaceutical price target raised to $82 from $80 at H.C. Wainwright TARO Taro Pharmaceutical $48.58 / -0.825 (-1.67%) 10/28/21 Taro Pharmaceutical reports Q2 EPS 66c, one estimate $1.02 07/27/21 Taro Pharmaceutical reports Q1 EPS $1.09, one estimate 84c

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Empire State Manufacturing Index: January 2022 Government Event
FTCI
Today at 08:30

FTC Solar - FTCI Conference Calls
PNC
Today at 09:30

PNC Financial - PNC Conference Calls
GS
Today at 09:30

Goldman Sachs - GS Conference Calls
Today at 10:00

Housing Market Index: January 2022 Government Event
Today at 10:00

Business & Information Services Industry Meetings
MSFT ...
Today at 10:00

Technology Industry Meetings
TFC
Today at 10:30

Truist Financial - TFC Conference Calls
Today at 11:00

4-Week Bill Announcement Government Event
Today at 11:00

8-Week Bill Announcement Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	JUNS X JUNS Jupiter Neurosciences IPO Managers: Roth Capital & Desjardins $5.00-7.00 3.333M Shares
Tues	No deals
Wed	FSPR X FSPR Four Springs Capital IPO Managers: Morgan Stanley, Goldman Sachs & Wells Fargo, Mizuho, Scotiabank, Nomura, Berenberg $13.00-15.00 18M Shares RHDM X RHDM Rhodium Enterprises IPO Managers: B. Riley & Cowen, Needham, DA Davidson, Northland $12.00-14.00 7.692M Shares
Thurs	SMSA X SMSA Samsara Vision IPO Managers: ThinkEquity $5.00-7.00 28.75M Shares
Fri	No deals

View All Syndicate Announcements »

Main Street announces new portfolio investments

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access